Acadia Healthcare (NASDAQ:ACHC) Stock Rating Upgraded by Zacks Research

Acadia Healthcare (NASDAQ:ACHC) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Thursday,Zacks.com reports.

A number of other research firms also recently issued reports on ACHC. KeyCorp dropped their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft decreased their price objective on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Raymond James Financial reissued an “outperform” rating and set a $25.00 target price on shares of Acadia Healthcare in a research report on Thursday, February 26th. Finally, Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, February 26th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.15.

Acadia Healthcare Trading Up 3.9%

Shares of NASDAQ:ACHC traded up $0.96 during trading on Thursday, reaching $25.62. 4,445,074 shares of the company were exchanged, compared to its average volume of 4,206,903. The business’s fifty day simple moving average is $15.80 and its 200-day simple moving average is $18.69. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.44. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $31.43. The firm has a market capitalization of $2.36 billion, a PE ratio of -2.10, a P/E/G ratio of 8.33 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. The company had revenue of $821.46 million for the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.Acadia Healthcare’s revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after buying an additional 2,350,760 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after buying an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after acquiring an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC lifted its position in Acadia Healthcare by 22.3% during the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after acquiring an additional 800,000 shares during the last quarter. Finally, UBS Group AG boosted its stake in Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after acquiring an additional 350,484 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.